North Central Cancer Treatment Group N0531: Phase II Trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (Q46796824)
Jump to navigation
Jump to search
scientific article published in October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | North Central Cancer Treatment Group N0531: Phase II Trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane) in combination with gemcitabine in patients with metastatic breast cancer |
scientific article published in October 2005 |
Statements
1 reference
North Central Cancer Treatment Group N0531: Phase II Trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (English)
1 reference
Edith A Perez
1 reference
Alvaro Moreno-Aspitia
1 reference
1 October 2005
1 reference
6
1 reference
4
1 reference
361-364
1 reference